Netherlands

Principal investigator: Dr EE Lutge (Health Systems Trust)

In collaboration with Professor JA Volmink (University of Stellenbosch) and Dr SA Lewin (Medical Research Council South Africa)

Additional technical assistance for protocol development and data analysis provided by KNCV Tuberculosis Foundation.

Funded by the National Department of Health (South Africa), the Tuberculosis Control

Assistance Program (TB CAP), (the Netherlands, through the National TB Directorate) and the Wellcome Trust (United Kingdom).

The last decade saw a dramatic rise in resources devoted to addressing the HIV epidemic in low- and middle- income countries, contributing to significant scale up of treatment and prevention efforts. In marking the 30th year of the epidemic, UNAIDS recently reported that treatment access had increased more than 20 times and new infections fell by nearly 25% over the decade.1